News Stories

The 2013 Impact Factors were recently released and the Journal of Clinical Lipidology (JCL) saw a significant increase — from 2.741 (2012) to 3.587. The Journal is now ranked 53rd out of 254 journals in its category (pharmacology and pharmacy). 

The results of the HPS2-THRIVE study were released in the New England Journal of Medicine on July 17, 2014. Also, appearing in the same edition was a special correspondence from the AIM HIGH investigators concerning further analysis of adverse events, and an editorial addressing both of these publications.

(JACKSONVILLE, FLA.)—The National Lipid Association (NLA) recently elected new officers to serve a one-year term on its Board of Directors. The election came just prior to the organization’s Annual Scientific Sessions held May 1–4 in Orlando, Fla.

Terry A. Jacobson, MD, FNLA was elected president of the NLA.